Katayoun Amiri
Overview
Explore the profile of Katayoun Amiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
13
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langer C, Kim E, Anderson E, Jotte R, Modiano M, Haggstrom D, et al.
Front Oncol
. 2018 Aug;
8:262.
PMID: 30087851
The phase 4 ABOUND.70+ trial assessed the safety and efficacy of -paclitaxel/carboplatin continuously or with a 1-week break between cycles in elderly patients with advanced non-small cell lung cancer (NSCLC)....
2.
Gajra A, Karim N, Mulford D, Villaruz L, Matrana M, Ali H, et al.
Front Oncol
. 2018 Aug;
8:253.
PMID: 30087850
Introduction: The phase II ABOUND.PS2 study (NCT02289456) assessed safety/tolerability of a first-line modified -paclitaxel/carboplatin regimen for patients with advanced non-small cell lung cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)...